Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | STAT6 | P42226 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hemiasterlin SCHEMBL22692376 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL14567797 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL13850381 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL57334 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL57313 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL29421592 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL14115433 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| Hemiasterlin SCHEMBL13203800 | 1.00 | TUBB1 (0.61) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| SCHEMBL26607783 | 0.94 | TUBB1 (0.53) | TUBB1GLAALDH1A1SMN1; SMN2NR4A2 | |
| SCHEMBL58604 | 0.93 | TUBB1 (0.52) | TUBB1GLAALDH1A1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4643 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083866-A1 | COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-26 | — | — | US | claimed |
| EP-4714971-A1 | ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2026-03-25 | — | — | EP | claimed |
| EP-4704904-A1 | TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD | Tambo, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4695300-A2 | ANTIBODIES AND CONJUGATES AGAINST PROSTAGLANDIN F2 RECEPTOR INHIBITOR AND USES THEREOF | A & G Pharmaceutical, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4684807-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-01-28 | — | — | EP | claimed |
| US-20260007763-A1 | PEGYLATED ANTIBODY HYDROXYL-BEARING DRUG CONJUGATE | SHENZHEN ENDURING BIOTECH, LTD. (CN) | 2026-01-08 | — | — | US | claimed |
| US-20260001950-A1 | METHODS OF ENHANCING EFFICACY OF IMMUNOCONJUGATES USING PAIRED HUMAN ANTIBODIES TARGETED AT NON-OVERLAPPING B-CELL EPITOPES ON THE SAME ANTIGEN | MEDICOVESTOR INC (US) | 2026-01-01 | — | — | US | claimed |
| US-20250387499-A1 | LIGAND-PAYLOAD CONJUGATES | PYXIS ONCOLOGY, INC. (US) | 2025-12-25 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-0839154-B1 | BIOLOGICALLY ACTIVE PEPTIDES AND COMPOSITIONS, THEIR USE | UNIV BRITISH COLUMBIA (CA) | 2003-12-17 | — | — | EP | claimed |
| WO-2003082268-A2 | HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER | EISAI CO. LTD (JP) | 2003-10-09 | — | — | WO | claimed |
| WO-2003072754-A2 | CONJUGATES OF LIGAND, LINKER AND CYTOTOXIC AGENT AND RELATED COMPOSITIONS AND METHODS OF USE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-09-04 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-1263762-A4 | ANTI-INFECTIVE ECTATM | NEWBIOTICS INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1263762-A1 | ANTI-INFECTIVE ECTATM | Newbiotics Inc. (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001064687-A1 | ANTI-INFECTIVE ECTA?TM¿ | NEWBIOTICS, INC. (US) | 2001-09-07 | — | — | WO | claimed |
| EP-0839154-A1 | BIOLOGICALLY ACTIVE PEPTIDES AND COMPOSITIONS, THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1998-05-06 | — | — | EP | claimed |
| US-5661175-A | ANTITUMOR AGENTS; CYTOTOXIC PEPTIDES | PHARMA MAR, S.A. (ES) | 1997-08-26 | — | — | US | claimed |
| WO-1996033211-A1 | BIOLOGICALLY ACTIVE PEPTIDES AND COMPOSITIONS, THEIR USE | UNIVERSITY OF BRITISH COLUMBIA (CA) | 1996-10-24 | — | — | WO | claimed |